CorneaGen
  • SURGEON PORTAL
  • Contact Us
  • CORNEAL TISSUE
    • Tissue Overview
    • Tissue Services
      • DSAEK
      • DMEK
      • Geuder Pre-Loaded Glass Cannula
      • Ampho B
      • PKP
      • ALK
      • FLAK
      • VisionGraft
      • Sclera
    • Reimbursement Assistance
    • Adverse Reaction Reporting
    • Regulatory Information
    • Request Tissue
  • Products
    • Products Overview
    • Corneal Products
      • EndoSerter
      • Cannula
      • Geuder Pre-Loaded Glass Cannula
      • Donor Punch
      • Recipient Trephine
      • Intacs
  • Innovation
  • Education
    • Educational Videos
    • Wet Labs
    • Fellows Program
  • About Us
    • Our People
    • Our Partners
    • Gift of Sight
    • Core Commitments
    • Careers
    • Our Locations
    • News & Events
Request Tissue Contact Us
Christine Z. McCauley of Edwards Lifesciences Joins CorneaGen Board of Directors

Christine Z. McCauley of Edwards Lifesciences Joins CorneaGen Board of Directors

May 31, 2019

CorneaGen, a mission-driven company committed to transforming how corneal surgeons treat and care for the cornea, today announced that Christine Z. McCauley has joined the CorneaGen board of directors. An experienced leader in the medical technology industry, McCauley is currently corporate vice president, human resources, at Edwards Lifesciences Corporation. She has more than 30 years of experience in human resources and has played a key role in the exponential growth of Edwards since it became an independent, publicly traded company in 2000.

“CorneaGen has a compelling mission focused on transforming treatment for patients in need of cornea care, and I am pleased to join the board to help support their work for patients worldwide,” said McCauley. “It is motivating to be affiliated with companies that have bold goals to impact the outcomes of people facing serious health issues, and I look forward to being engaged with CorneaGen as they pursue their mission to eliminate corneal blindness worldwide.”

McCauley has been a leader with the human resources team at Edwards since 1999 when the company had approximately 5,000 employees and net sales of $809 million. Today, the $3.7 billion company has more than 13,000 employees around the world. McCauley previously held human resources positions at Texas Instruments, Loral (Ford) Aerospace and Bally’s Health and Tennis.

“Christine’s experience in a high-growth, publicly traded company is unanimously valued and respected by our leadership team,” said CorneaGen President and CEO Monty Montoya. “We anticipate that CorneaGen will go through many of the phases of growth that Christine has experienced as an executive leader at Edwards, and we look forward to her guidance and support of our mission.”

McCauley also is a member of the board of directors and chairs the board’s nominating/ governance committee at Baxter Credit Union. She earned a dual bachelor’s degree in business administration and organizational effectiveness at The College at Brockport State University of New York and a master’s degree in human resource management from Chapman University

About CorneaGen

CorneaGen is a mission-driven company committed to transforming how corneal surgeons treat and care for the cornea. Based in Seattle, the company is innovating the next generation of cornea care, from new medical devices and biologics to treatments and interventions. CorneaGen supports corneal surgeons and their patients with a spectrum of services, including the latest in innovative products, delivery of the highest quality tissue, surgeon education, and advocacy for patient access and reimbursement policies. https://corneagen.com

Recent Articles

  • Tom Frinzi Joins CorneaGen Board as Executive Chair

    Tom Frinzi Joins CorneaGen Board as Executive Chair

    CorneaGen, a mission-driven company committed to transforming how corneal surgeons...

    READ MORE
  • David Rostov Joins CorneaGen as Chief Financial Officer

    David Rostov Joins CorneaGen as Chief Financial Officer

    CorneaGen, a mission-driven company committed to transforming how corneal surgeons...

    READ MORE
  • CorneaGen Raises $37 Million to Advance Development of Cornea Cell Therapy

    CorneaGen, a mission-driven company committed to transforming how corneal surgeons...

    READ MORE
  • CorneaGen to Acquire KeraLink Domestic Eye Bank Operations

    CorneaGen to Acquire KeraLink Domestic Eye Bank Operations

    CorneaGen, a mission-driven company committed to transforming how corneal surgeons...

    READ MORE
Navigation
  • Corneal Tissue
  • Products
  • Innovation
  • Education
  • About Us
  • Request Tissue
Helpful Information
  • Reimbursement assistance
  • Adverse reaction reporting
  • KAMRA Support
  • Careers
Legal
  • Privacy Policy
  • Terms and conditions
  • Regulatory Information
Connect
  • Contact Us
CorneaGen

©2021 CorneaGen

CorneaGen